Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation (Q36611112)

15 August 2017

Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation (English)

1 reference

15 August 2017

1 reference

9

G Fountzilas

1 reference

15 August 2017

10

G P Chrousos

1 reference

15 August 2017

V Minas

1

1 reference

15 August 2017

A Rolaki

2

1 reference

15 August 2017

S N Kalantaridou

3

1 reference

15 August 2017

J Sidiropoulos

4

1 reference

15 August 2017

S Mitrou

5

1 reference

15 August 2017

G Petsas

6

1 reference

15 August 2017

U Jeschke

7

1 reference

15 August 2017

E A Paraskevaidis

8

1 reference

15 August 2017

N Pavlidis

11

1 reference

15 August 2017

A Makrigiannakis

12

1 reference

15 August 2017

language of work or name

English

0 references

publication date

31 July 2007

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

97

1 reference

15 August 2017

5

1 reference

15 August 2017

637-645

1 reference

describes a project that uses

15 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2360374/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Upregulation of FasL by LPA on ovarian cancer cell surface leads to apoptosis of activated lymphocytes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

CRF and CRF receptors: role in stress responsivity and other behaviors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

The Fas counterattack: cancer as a site of immune privilege

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Human lung carcinomas express Fas ligand.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Expression of the Fas ligand in cells of T cell lineage.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Epithelial ovarian cancer cells secrete functional Fas ligand

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Corticotropin-releasing factor inhibits luteinizing hormone-stimulated P450c17 gene expression and androgen production by isolated thecal cells of human ovarian follicles

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Expression of Fas and FasL in human serous ovarian epithelial tumors

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360374

Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis

4 December 2018

1 reference

12 December 2020

CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis

1 reference

12 December 2020

Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen

1 reference

12 December 2020

Immune privilege or inflammation? Insights into the Fas ligand enigma

1 reference

12 December 2020

The expression of corticotropin-releasing hormone in melanoma

1 reference

12 December 2020

Expression of CRF1 and CRF2 receptors in human cancers

1 reference

12 December 2020

Characterization of immunoreactive corticotropin and corticotropin-releasing factor in human adrenal and ovarian tumours

1 reference

12 December 2020

Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients

1 reference

12 December 2020

A role for CD95 ligand in preventing graft rejection

1 reference

12 December 2020

Corticotropin-releasing hormone (CRH) inhibits steroid biosynthesis by cultured human granulosa-lutein cells in a CRH and interleukin-1 receptor-mediated fashion

1 reference

12 December 2020

Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer

1 reference

12 December 2020

Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes

1 reference

12 December 2020

FasL:Fas ratio--a prognostic factor in breast carcinomas

1 reference

12 December 2020

Prognostic relevance of altered Fas (CD95)-system in human breast cancer

1 reference

12 December 2020

Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6603918

1 reference

release_xgekmzynmzdh5bwef2rhrng3o4

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xgekmzynmzdh5bwef2rhrng3o4

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

17667919

1 reference